374 related articles for article (PubMed ID: 8604395)
1. Transfected neu oncogene induces human prostate cancer metastasis.
Zhau HY; Zhou J; Symmans WF; Chen BQ; Chang SM; Sikes RA; Chung LW
Prostate; 1996 Feb; 28(2):73-83. PubMed ID: 8604395
[TBL] [Abstract][Full Text] [Related]
2. Acquisition of a tumorigenic phenotype by a rat ventral prostate epithelial cell line expressing a transfected activated neu oncogene.
Sikes RA; Chung LW
Cancer Res; 1992 Jun; 52(11):3174-81. PubMed ID: 1350510
[TBL] [Abstract][Full Text] [Related]
3. Reversion of human prostate tumorigenic growth by azatyrosine.
Benoit RM; Eiseman J; Jacobs SC; Kyprianou N
Urology; 1995 Sep; 46(3):370-7. PubMed ID: 7660512
[TBL] [Abstract][Full Text] [Related]
4. Transfer of a dominant-acting tumor-inducing oncogene from human prostatic carcinoma cells to cloned rat embryo fibroblast cells by DNA-transfection.
Su ZZ; Olsson CA; Zimmer SG; Fisher PB
Anticancer Res; 1992; 12(2):297-304. PubMed ID: 1580547
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers associated with prostate cancer progression.
Zhau HE; Pisters LL; Hall MC; Zhao LS; Troncoso P; Pollack A; Chung LW
J Cell Biochem Suppl; 1994; 19():208-16. PubMed ID: 7529853
[TBL] [Abstract][Full Text] [Related]
6. Expression of activated rat neu oncogene is sufficient to induce experimental metastasis in 3T3 cells.
Yu DH; Hung MC
Oncogene; 1991 Nov; 6(11):1991-6. PubMed ID: 1682865
[TBL] [Abstract][Full Text] [Related]
7. Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors.
Bacus SS; Gudkov AV; Zelnick CR; Chin D; Stern R; Stancovski I; Peles E; Ben-Baruch N; Farbstein H; Lupu R
Cancer Res; 1993 Nov; 53(21):5251-61. PubMed ID: 8106145
[TBL] [Abstract][Full Text] [Related]
8. c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties.
Yu D; Wang SS; Dulski KM; Tsai CM; Nicolson GL; Hung MC
Cancer Res; 1994 Jun; 54(12):3260-6. PubMed ID: 7911396
[TBL] [Abstract][Full Text] [Related]
9. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A.
Yu D; Wolf JK; Scanlon M; Price JE; Hung MC
Cancer Res; 1993 Feb; 53(4):891-8. PubMed ID: 8094034
[TBL] [Abstract][Full Text] [Related]
10. EJ/ras neoplastic transformation of simian virus 40-immortalized human uroepithelial cells: a rare event.
Christian BJ; Kao CH; Wu SQ; Meisner LF; Reznikoff CA
Cancer Res; 1990 Aug; 50(15):4779-86. PubMed ID: 2164447
[TBL] [Abstract][Full Text] [Related]
11. The presence of prostate-specific antigen-related genes in primates and the expression of recombinant human prostate-specific antigen in a transfected murine cell line.
Karr JF; Kantor JA; Hand PH; Eggensperger DL; Schlom J
Cancer Res; 1995 Jun; 55(11):2455-62. PubMed ID: 7538903
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
Hal DG; Stoica G
Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
[TBL] [Abstract][Full Text] [Related]
13. Correlation of growth capacity of cells in hard agarose with successful transfection by the activated c-Ha-ras oncogene and in vivo proliferative capacity at metastatic sites.
Fidler IJ; Li LM; Ananthaswamy HN; Esumi N; Radinsky R; Price JE
Anticancer Res; 1991; 11(1):17-24. PubMed ID: 2018350
[TBL] [Abstract][Full Text] [Related]
14. The role of v-mos in transformation, oncogenicity, and metastatic potential of mink lung cells.
Gao CL; Wang LC; Vass WC; Seth A; Chang KS
Oncogene; 1988 Sep; 3(3):267-73. PubMed ID: 2849740
[TBL] [Abstract][Full Text] [Related]
15. Relationship between metastatic ability and H-ras oncogene expression in rat mammary cancer cells transfected with the v-H-ras oncogene.
Kyprianou N; Isaacs JT
Cancer Res; 1990 Mar; 50(5):1449-54. PubMed ID: 2105838
[TBL] [Abstract][Full Text] [Related]
16. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).
Lavialle C; Modjtahedi N; Lamonerie T; Frebourg T; Landin RM; Fossar N; Lhomond G; Cassingena R; Brison O
Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529
[TBL] [Abstract][Full Text] [Related]
17. Metastatic potential of cloned murine melanoma cells transfected with activated c-Ha-ras.
Price JE; Aukerman SL; Ananthaswamy HN; McIntyre BW; Schackert G; Schackert HK; Fidler IJ
Cancer Res; 1989 Aug; 49(15):4274-81. PubMed ID: 2663141
[TBL] [Abstract][Full Text] [Related]
18. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer.
Taplin ME; Bubley GJ; Shuster TD; Frantz ME; Spooner AE; Ogata GK; Keer HN; Balk SP
N Engl J Med; 1995 May; 332(21):1393-8. PubMed ID: 7723794
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of c-erbB2/neu oncogene-induced metastasis and repression of metastatic properties by adenovirus 5 E1A gene products.
Yu D; Hamada J; Zhang H; Nicolson GL; Hung MC
Oncogene; 1992 Nov; 7(11):2263-70. PubMed ID: 1359495
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene.
Zhai YF; Beittenmiller H; Wang B; Gould MN; Oakley C; Esselman WJ; Welsch CW
Cancer Res; 1993 May; 53(10 Suppl):2272-8. PubMed ID: 8097963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
